News, Short Squeeze, Breakout and More Instantly...
Penumbra, Inc. Reports First Quarter 2022 Financial Results PR Newswire ALAMEDA, Calif. , May 3, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first q...
Penumbra, Inc. to Present at the Bank of America Securities 2022 Healthcare Conference PR Newswire ALAMEDA, Calif. , April 26, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Ban...
Physicians in Europe now have access to Penumbra’s most advanced mechanical thrombectomy technology available, which has had a significant impact on patients in the U.S. Designed for single session blood clot removal in peripheral arterial and venous systems, including the ...